Braintree Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BRAINTREE, and when can generic versions of BRAINTREE drugs launch?
BRAINTREE has nine approved drugs.
There are five US patents protecting BRAINTREE drugs.
Drugs and US Patents for Braintree
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Braintree Labs | SUTAB | magnesium sulfate; potassium chloride; sodium sulfate | TABLET;ORAL | 213135-001 | Nov 10, 2020 | RX | Yes | Yes | 11,033,498 | ⤷ Sign Up | ⤷ Sign Up | ||||
Braintree Labs | SUTAB | magnesium sulfate; potassium chloride; sodium sulfate | TABLET;ORAL | 213135-001 | Nov 10, 2020 | RX | Yes | Yes | 11,638,697 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Braintree Labs | PIZENSY | lactitol | FOR SOLUTION;ORAL | 211281-001 | Feb 12, 2020 | DISCN | Yes | No | 10,806,743 | ⤷ Sign Up | ⤷ Sign Up | ||||
Braintree | HALFLYTELY | bisacodyl; polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride | FOR SOLUTION, TABLET, DELAYED RELEASE;ORAL | 021551-003 | Jul 16, 2010 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Braintree
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Braintree | HALFLYTELY | bisacodyl; polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride | FOR SOLUTION, TABLET, DELAYED RELEASE;ORAL | 021551-003 | Jul 16, 2010 | 7,291,324 | ⤷ Sign Up |
Braintree Labs | SUPREP BOWEL PREP KIT | magnesium sulfate; potassium sulfate; sodium sulfate | SOLUTION;ORAL | 022372-001 | Aug 5, 2010 | 6,946,149 | ⤷ Sign Up |
Braintree | AXID | nizatidine | SOLUTION;ORAL | 021494-001 | May 25, 2004 | 6,930,119 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for BRAINTREE drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | For Oral Solution and Delayed- | 210 g, 5.6 g, 0.74 g, 2.86 g and 5 mg | ➤ Subscribe | 2008-01-28 |
➤ Subscribe | Oral Solution | 15 mg/mL | ➤ Subscribe | 2008-05-14 |
➤ Subscribe | For Oral Solution and Delayed-release Tablet | 210 g, 5.6 g, 0.74 g, 2.86 g and 5 mg (1 Tablet Regimen) | ➤ Subscribe | 2010-07-30 |
➤ Subscribe | Oral Solution | 17.5 g/3.13 g/1.6 g per bottle | ➤ Subscribe | 2010-11-08 |
Similar Applicant Names
Here is a list of applicants with similar names.